Results · Apr-Jun 2026
Kothari Fermanatation & Biochem Q1 FY27 results
Sales grew 28% to ₹30.4 crore from ₹23.8 crore in Apr-Jun 2025.
Operating profit grew 60% to ₹2.7 crore, an operating margin of 8.7% (up 1.7 points from a year ago).
Net profit turned positive: ₹0.06 crore against a loss of ₹1.1 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −6%, net profit −95%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 30.4 | 23.8 | +28% |
| Operating profit (EBITDA) | 2.7 | 1.7 | +60% |
| Operating margin | 8.7% | 7.0% | +1.7 pts |
| Net profit | 0.1 | -1.1 | turns positive |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.